1. Stewart, B.W., Kleihues, P.: World Cancer Report World Health Organization, International Agency for Research on Cancer (2003)
2. Kronz J.D., Westra W.H., Epstein J.I.: Mandatory second opinion surgical pathology at a Large Referral Hospital. Cancer 86(11), 2426–2435 (1999)
3. Bartels P.H. et al.: Nuclear chromatin texture in prostatic lesions: IPIN and adenocarcinoma. Anal. Quant. Cytol. Histol. 20(15), 389–396 (1998)
4. Clark T.D., Askin F.B., Bagnell C.R.: Nuclear roundness factor: a quantitative approach to grading in prostate carcinoma. Reliability of needle biopsy tissue, and the effect of tumor stage on usefulness. Prostate 10(3), 199–206 (1987)
5. Gleason, D.F., Tannenbaum, M. (eds.): The veteran’s administration cooperative urologic research group: histologic grading and clinical staging of prostatic carcinoma. In: Urologic Pathology: The Prostate, pp. 171–198, Lea Febiger, Philadephia (1977)